No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Affiliations

• ¹ Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
• ² Department of Hematology, Uppsala University Hospital, Sweden.
• ³ Institute of Applied Biosciences, Thessaloniki, Greece.
• ⁴ Università Vita-Salute San Raffaele, Milan, Italy.
• ⁵ Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
• ⁶ Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
• ⁷ The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
• ⁸ CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
• ⁹ University Hospital Brno, Czech Republic.
• ¹⁰ Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
• ¹¹ Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
• ¹² First Department of Propaedeutic Medicine, University of Athens, Greece.
• ¹³ Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
• ¹⁴ Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
• ¹⁵ IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France.
• ¹⁶ Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
• ¹⁷ Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden.
• ¹⁸ Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
• ¹⁹ Department of Medicine, Hematology and Clinical Immunology Branch, Padova University School of Medicine, Italy.
• ²⁰ Venetian Institute of Molecular Medicine, Padova, Italy.
• ²¹ Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK.
• ²² Department of Immunology, Mayo Clinic, Rochester, MV, USA.
• ²³ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
• ²⁴ Hematology Department, Nikea General Hospital, Piraeus, Greece.
• ²⁵ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
• ²⁶ Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden kostas.stamatopoulos@gmail.com.